Difference between revisions of "Thyroid blocking"
Jump to navigation
Jump to search
(Created page with "Administration of a compound of stable iodine (usually potassium iodide) to prevent or reduce the unwanted uptake of radioactive isotopes of iodine by the thyroid in the event...") |
|||
| Line 1: | Line 1: | ||
Administration of a compound of stable iodine (usually potassium iodide) to prevent or reduce the unwanted uptake of radioactive isotopes of iodine by the thyroid in the event of an accident involving radioactive iodine or in patients administered radioiodine containing radiopharmaceuticals where there is the potential for the presence of unbound or “free” iodine (e.g. 123I or 131I). | Administration of a compound of stable iodine (usually potassium iodide) to prevent or reduce the unwanted uptake of radioactive isotopes of iodine by the thyroid in the event of an accident involving radioactive iodine or in patients administered radioiodine containing radiopharmaceuticals where there is the potential for the presence of unbound or “free” iodine (e.g. 123I or 131I). | ||
| + | ''ICRP Glossary entry - May 2019'' | ||
| − | ''[[ICRP Glossary]] | + | |
| + | '''Return to [[ICRP Glossary|Glossary]]''' | ||
Latest revision as of 14:11, 13 September 2019
Administration of a compound of stable iodine (usually potassium iodide) to prevent or reduce the unwanted uptake of radioactive isotopes of iodine by the thyroid in the event of an accident involving radioactive iodine or in patients administered radioiodine containing radiopharmaceuticals where there is the potential for the presence of unbound or “free” iodine (e.g. 123I or 131I).
ICRP Glossary entry - May 2019
Return to Glossary
